Korean Vs Global Biopharma M&A Trends: How Different Are They?
Korean Family Firms Link With Outsiders
A number of recent significant transactions in the South Korean biopharma space indicate some emerging trends as the sector develops and expands internationally. Scrip takes a look at the over-arching themes in M&A activity over the past few years and how these may differ from those being observed globally.
